Brainstem Glioma

11 registered clinical trials studyying Brainstem Glioma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Vegetative Monitoring During Brainstem-associated Surgery NCT03666507	University Hospital Tuebingen	—
Completed	A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied NCT03355794	Children's Hospital Medical Center, Cincinnati	Phase 1
Completed	Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas NCT03178032	Clinica Universidad de Navarra, Universidad de Navarra	Phase 1
Withdrawn	Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas NCT02976441	Washington University School of Medicine	EARLY_Phase 1
Completed	A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas NCT01837862	Julie Krystal	Phase 1 / Phase 2
Completed	AZD8055 for Adults With Recurrent Gliomas NCT01316809	National Cancer Institute (NCI)	Phase 1
Withdrawn	A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas NCT01117155	National Cancer Institute (NCI)	—
Recruiting	Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma NCT01106794	Children's National Research Institute	—
Completed	Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Gli NCT00879437	Baylor College of Medicine	Phase 2
Completed	A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem NCT01118377	Hoffmann-La Roche	Phase 2
Completed	ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors NCT01756989	Helsinki University Central Hospital	Phase 2